Figure 3
Figure 3. Sorted CD14+ gp91phox + mature malignant from FAB M4/M5 AML produce ROS. (A) A representative set of FACS plots of a FAB-M4 AML patient (patient 6) with 2 distinct myeloid populations, one immature blast population CD34+CD33−CD14− (green) and one monocyte-like CD34−CD33+CD14+ (blue) population, is shown. (B,C) FACS-sorted mature CD14+ leukemic cells (blue) and immature CD34+ leukemic cells (green) were stimulated with PMA and assayed for ROS production. Panel B shows the kinetics of a representative experiment, and panel C shows total ROS production (n = 3, patients 5-7).

Sorted CD14+ gp91phox + mature malignant from FAB M4/M5 AML produce ROS. (A) A representative set of FACS plots of a FAB-M4 AML patient (patient 6) with 2 distinct myeloid populations, one immature blast population CD34+CD33CD14 (green) and one monocyte-like CD34CD33+CD14+ (blue) population, is shown. (B,C) FACS-sorted mature CD14+ leukemic cells (blue) and immature CD34+ leukemic cells (green) were stimulated with PMA and assayed for ROS production. Panel B shows the kinetics of a representative experiment, and panel C shows total ROS production (n = 3, patients 5-7).

Close Modal

or Create an Account

Close Modal
Close Modal